Approval · Notice of Compliance 11593 · 2010
APO-VALACYCLOVIR: Notice of Compliance 11593
Issued July 16, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11593
- Date
- July 16, 2010
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength, change in formulation
- Therapeutic class
- Antiviral
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-VALACYCLOVIR | 02354705 | Marketed |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 1,000 MG per TAB